Results 181 to 190 of about 45,683 (251)

Correlates of Rural Naloxone Possession Among People Who Use Drugs: A Multi-State Cross-Sectional Analysis. [PDF]

J Rural Health
Moore PQ, Mixson LS, Bolinski R, Colston DC, Cooper HLF, Crane HM, Devadas J, Feinberg J, Friedmann PD, Gicquelais RE, Jenkins WD, Khoury D, Korthuis PT, Smith G, Stopka TJ, Westergaard R, Young A, Pho MT.   +17 more
europepmc   +1 more source

Transcriptional Reprogramming of GPCR Signaling Pathways in the Frontal Cortex of Morphine Dependent Mice. [PDF]

Biomol Ther (Seoul)
Kim M, Moon S, Yayeh T, Villa T, Oh S.
europepmc   +1 more source

Differential Impacts of Methadone and Buprenorphine/Naloxone on Pain-Related Outcomes Among People With Non-Heroin Opioid Use Disorder: Secondary Analyses From a Pragmatic Canadian Multisite Trial. [PDF]

Drug Alcohol Rev
Lyman K, Choi J, Jutras-Aswad D, Le Foll B, Klaire S, Socias ME.   +5 more
europepmc   +1 more source

Public perceptions and willingness-to-pay regarding over-the-counter (OTC) naloxone: A national cross-sectional survey informed by the Theory of Planned Behavior. [PDF]

Explor Res Clin Soc Pharm
Randles A, Tidmore E, Smith K, Sanders M, White A, Given A, Contreras AU, Rodriguez-Ramos A, Carter C, Taylor A, McCormick N, Davis B, Hohmann L.   +12 more
europepmc   +1 more source

Naloxone administration associated with improved survival in PEA out-of-hospital cardiac arrests. [PDF]

Resuscitation
Niederberger SM, Wang RC, Rodriguez RM, Montoy JCC, Crowe RP, Menegazzi JJ, Dillon DG.   +6 more
europepmc   +1 more source

Troubles liés à l’usage d’opioïdes en milieu carcéral: Continuité du traitement par agonistes opioïdes à une étape cruciale du parcours clinique. [PDF]

Can Fam Physician
Albert OM, Arthur A, Beshara F.
europepmc   +1 more source

Regression Not-to-the-Mean: An Oddity of Regression, Illustrated With the Risk of Overdose Deaths. [PDF]

Stat Med
Kung KC, Martin NK, Lok JJ.
europepmc   +1 more source